302 related articles for article (PubMed ID: 28390160)
1. The role of small GTPases of the Rho/Rac family in TGF-β-induced EMT and cell motility in cancer.
Ungefroren H; Witte D; Lehnert H
Dev Dyn; 2018 Mar; 247(3):451-461. PubMed ID: 28390160
[TBL] [Abstract][Full Text] [Related]
2. The role of TGF-β and its crosstalk with RAC1/RAC1b signaling in breast and pancreas carcinoma.
Melzer C; Hass R; von der Ohe J; Lehnert H; Ungefroren H
Cell Commun Signal; 2017 May; 15(1):19. PubMed ID: 28499439
[TBL] [Abstract][Full Text] [Related]
3. RAC1B: A Guardian of the Epithelial Phenotype and Protector Against Epithelial-Mesenchymal Transition.
Zinn R; Otterbein H; Lehnert H; Ungefroren H
Cells; 2019 Dec; 8(12):. PubMed ID: 31817229
[TBL] [Abstract][Full Text] [Related]
4. TGF-β-Dependent Growth Arrest and Cell Migration in Benign and Malignant Breast Epithelial Cells Are Antagonistically Controlled by Rac1 and Rac1b.
Melzer C; von der Ohe J; Hass R; Ungefroren H
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28726720
[TBL] [Abstract][Full Text] [Related]
5. Negative regulation of TGF-β1-induced MKK6-p38 and MEK-ERK signalling and epithelial-mesenchymal transition by Rac1b.
Witte D; Otterbein H; Förster M; Giehl K; Zeiser R; Lehnert H; Ungefroren H
Sci Rep; 2017 Dec; 7(1):17313. PubMed ID: 29229918
[TBL] [Abstract][Full Text] [Related]
6. Rac1b negatively regulates TGF-β1-induced cell motility in pancreatic ductal epithelial cells by suppressing Smad signalling.
Ungefroren H; Sebens S; Giehl K; Helm O; Groth S; Fändrich F; Röcken C; Sipos B; Lehnert H; Gieseler F
Oncotarget; 2014 Jan; 5(1):277-90. PubMed ID: 24378395
[TBL] [Abstract][Full Text] [Related]
7. Different signaling and functionality of Rac1 and Rac1b in the progression of lung adenocarcinoma.
Seiz JR; Klinke J; Scharlibbe L; Lohfink D; Heipel M; Ungefroren H; Giehl K; Menke A
Biol Chem; 2020 Mar; 401(4):517-531. PubMed ID: 31811797
[TBL] [Abstract][Full Text] [Related]
8. TGF-β-induced cell motility requires downregulation of ARHGAPs to sustain Rac1 activity.
Motizuki M; Koinuma D; Yokoyama T; Itoh Y; Omata C; Miyazono K; Saitoh M; Miyazawa K
J Biol Chem; 2021; 296():100545. PubMed ID: 33741342
[TBL] [Abstract][Full Text] [Related]
9. Paving the Rho in cancer metastasis: Rho GTPases and beyond.
Jansen S; Gosens R; Wieland T; Schmidt M
Pharmacol Ther; 2018 Mar; 183():1-21. PubMed ID: 28911825
[TBL] [Abstract][Full Text] [Related]
10. BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study.
Makrodouli E; Oikonomou E; Koc M; Andera L; Sasazuki T; Shirasawa S; Pintzas A
Mol Cancer; 2011 Sep; 10():118. PubMed ID: 21943101
[TBL] [Abstract][Full Text] [Related]
11. Loss of TAK1 increases cell traction force in a ROS-dependent manner to drive epithelial-mesenchymal transition of cancer cells.
Lam CR; Tan C; Teo Z; Tay CY; Phua T; Wu YL; Cai PQ; Tan LP; Chen X; Zhu P; Tan NS
Cell Death Dis; 2013 Oct; 4(10):e848. PubMed ID: 24113182
[TBL] [Abstract][Full Text] [Related]
12. Pro-migratory and TGF-β-activating functions of αvβ6 integrin in pancreatic cancer are differentially regulated via an Eps8-dependent GTPase switch.
Tod J; Hanley CJ; Morgan MR; Rucka M; Mellows T; Lopez MA; Kiely P; Moutasim KA; Frampton SJ; Sabnis D; Fine DR; Johnson C; Marshall JF; Scita G; Jenei V; Thomas GJ
J Pathol; 2017 Sep; 243(1):37-50. PubMed ID: 28608476
[TBL] [Abstract][Full Text] [Related]
13. The Ratio of RAC1B to RAC1 Expression in Breast Cancer Cell Lines as a Determinant of Epithelial/Mesenchymal Differentiation and Migratory Potential.
Eiden C; Ungefroren H
Cells; 2021 Feb; 10(2):. PubMed ID: 33567745
[TBL] [Abstract][Full Text] [Related]
14. Distinctive requirement of PKCε in the control of Rho GTPases in epithelial and mesenchymally transformed lung cancer cells.
Casado-Medrano V; Barrio-Real L; Wang A; Cooke M; Lopez-Haber C; Kazanietz MG
Oncogene; 2019 Jul; 38(27):5396-5412. PubMed ID: 30923343
[TBL] [Abstract][Full Text] [Related]
15. The Small GTPase RAC1B: A Potent Negative Regulator of-and Useful Tool to Study-TGFβ Signaling.
Ungefroren H; Wellner UF; Keck T; Lehnert H; Marquardt JU
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33266416
[TBL] [Abstract][Full Text] [Related]
16. Differential roles of Src in transforming growth factor-ß regulation of growth arrest, epithelial-to-mesenchymal transition and cell migration in pancreatic ductal adenocarcinoma cells.
Ungefroren H; Sebens S; Groth S; Gieseler F; Fändrich F
Int J Oncol; 2011 Mar; 38(3):797-805. PubMed ID: 21225226
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of RhoE Expression Enhances TGF-β-Induced EMT (epithelial-to-mesenchymal transition) in Cervical Cancer HeLa Cells.
Nishizuka M; Komada R; Imagawa M
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31546735
[TBL] [Abstract][Full Text] [Related]
18. RAC1B: A Rho GTPase with Versatile Functions in Malignant Transformation and Tumor Progression.
Melzer C; Hass R; Lehnert H; Ungefroren H
Cells; 2019 Jan; 8(1):. PubMed ID: 30621237
[TBL] [Abstract][Full Text] [Related]
19. The Snail signaling branch downstream of the TGF-β/Smad3 pathway mediates Rho activation and subsequent stress fiber formation.
Motizuki M; Yokoyama T; Saitoh M; Miyazawa K
J Biol Chem; 2024 Jan; 300(1):105580. PubMed ID: 38141763
[TBL] [Abstract][Full Text] [Related]
20. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
